#Neurodegenerative Disease

[newsfromstolenland]

There’s a renewed call for a public inquiry into why so many New Brunswickers have come down with neurodegenerative symptoms and illnesses.

When an initial cluster of over 40 people presented with similar symptoms – muscle spasms, atrophy and progressive dementia – it was thought to be Creutzfeldt-Jakob disease, until they tested negative.

That’s when a Moncton-based neurologist thought they could be experiencing an unknown brain disease. The cluster was initially focused in the Moncton and Acadian Peninsula areas of the province.

But after over a year of confusing back-and-forth for patients and their families, the province of New Brunswick halted further investigation by its federal counterparts, saying there was an explanation for each patients’ illness.

This week, New York Times Magazine released an article that calls that into question, citing that neurologist Dr. Alier Marrero believes the number of people seeking help with similar symptoms is now over 400.

It has sparked Green Party MLA Megan Mitton to call for a public inquiry into what happened internally between the province and Ottawa, as well as further testing, including environmental, to try and find patients some answers.

Full article

Tagging: @allthecanadianpolitics

[bpod-bpod]

Mutation Walk

Discovery of a novel gene mutation associated with the inherited nervous system disease CMT; a fruit fly model with the mutation has gait problems reflecting those of CMT patients and reveals the molecular mechanisms underlying the peripheral nerve degeneration

Read the published research article here

Video from work by Jui-Yu Yeh and colleagues

Graduate Institute of Physiology, National Taiwan University, Taipei, Taiwan

Video originally published with a Creative Commons Attribution 4.0 International (CC BY 4.0)

Published in EMBO Molecular Medicine, April 2024

You can also follow BPoD on Instagram, Twitter and Facebook

[lire-casander]

the description tk makes of what they might look at with huntington's disease is the daily life of someone with any kind of neurodegenerative disease. even parkinson. or alzheimer.

especially alzheimer.

i wasn't expecting it to trigger me, not after 15.5 years.

but it did.

and here i am, still crying about what could have been and thinking of what an absolutely amazing way of facing it could be "hi, you're tk, i'm carlos, and we're soulmates"

[omegahospitals4]

Top Neurology Care in Hyderabad | Expert Neurologists | Omega

Experience top neurology care in Hyderabad at Omega Hospitals. Our experts treat neurodegenerative diseases with advanced and compassionate care.

[creativeera]

Amyotrophic Lateral Sclerosis Treatment: Current Perspectives on Amyotrophic Sclerosis Treatment

What is Amyotrophic Lateral Sclerosis Treatment? Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. The motor neurons, which are responsible for controlling voluntary muscle movement, gradually die in people with ALS. When the motor neurons die, it becomes very difficult to control muscle movement and eventually the muscles weaken and waste away. ALS usually affects people between the ages of 40 to 70 years. About 5-10% of ALS cases are considered familial, meaning they run in families. Most ALS cases are sporadic with no known family history. Men are slightly more likely than women to develop ALS. It is estimated that about 20,000 Americans may have the disease at any given time. Symptoms of ALS typically include slurred speech, muscle weakness, twitching or cramping, difficulty swallowing or breathing, and impaired walking or use of arms and hands. Most people with ALS lose their ability to speak, eat, move, and breathe within 3 to 5 years of diagnosis. The disease progresses differently in each individual and life expectancy can vary widely, with some people living for up to 10 years or more after symptoms first appear. Unfortunately, at this time there is no cure for ALS. Current Treatment Options While there is currently no cure for Amyotrophic Lateral Sclerosis Treatment, some treatments can help manage symptoms and quality of life for people living with the disease. The most common drug treatments for ALS include riluzole, edaravone, and dextromethorphan/quinidine. Riluzole (Rilutek) was the first FDA-approved drug for ALS in 1995. It is believed to work by blocking glutamate, a neurotransmitter that appears to play a role in motor neuron death. Riluzole has been shown to modestly extend survival by 2 to 3 months on average. Side effects may include nausea, fatigue, and liver problems. Edaravone (Radicava) was approved in 2017 as the second drug shown to slow functional decline in ALS. Clinical trials found edaravone reduced motor function decline over 6 months compared to a placebo. It is believed to work as an antioxidant, protecting cells from free radical damage. Side effects are generally mild and may include bruising, headache, and edema. Dextromethorphan/quinidine (Nuedexta) received FDA approval in 2011 as an add-on treatment for pseudobulbar affect, a condition that causes involuntary and unpredictable laughing or crying episodes unrelated to a person's feelings or mood. While not a treatment specifically for ALS motor symptoms, it can help manage this distressing symptom that sometimes occurs with ALS. Common side effects include diarrhea, nausea, dizziness, and vomiting. In addition to medications, other treatments that may help manage ALS symptoms include physical and occupational therapy to maintain mobility and function for as long as possible. Speech therapy can help address swallowing and speaking difficulties. Respiratory therapy and mechanical ventilation support, such as non-invasive ventilation, may improve breathing problems and quality of life. Nutritional supplements or feeding tubes help address weight loss or difficulty swallowing. Braces, walkers, and wheelchairs provide mobility assistance as needed. Stem Cell and Amyotrophic Lateral Sclerosis Treatment Exciting new avenues of research are exploring the potential of stem cell and gene therapies for ALS. Several clinical trials are investigating various approaches with the goal of replacing lost motor neurons or protecting and preserving existing motor neurons. One promising area involves transplanting motor neuron progenitor cells, stem cells that can develop into motor neurons, directly into the spinal cord. Early phase trials have begun testing the safety and potential benefits of this approach. Another trial is looking at transplanting olfactory bulb stem cells, which naturally migrate to the brain, into the lumbar region of the spinal cord. Get more insights on Amyotrophic Lateral Sclerosis Treatment

Get More Insights—Access the Report in the Language that Resonates with You

French

German

Italian

Russian

Japanese

Chinese

Korean

Portuguese

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.

(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)

[shopgirl724]

All I want for Christmas

Being sick isn’t fun for anyone but as a person with a neurodegenerative disease having something as simple as a cold can be tough. In my daily life I have these things that I call twitches, their not easy to describe but I feel something along the lines of a jolt of electricity in a random nerve that causes the subsequent muscle to freak out and involuntarily move. Thus twitch. Most of the time…

[emed123]

Recent Insights in Alzheimer Research |

Discover the latest insights into Alzheimers research, shedding light on advancements in diagnosis and treatment.

[wellhealthhub]

Grasping the Intricacies of Alzheimer's Disease Type 3: An Exploration of Its Causes, Symptoms, and Therapeutic Measures

Breaking Down Alzheimer’s Disease Type 3: An Initial Approach In the following exhaustive piece, we delve into the depths of Alzheimer’s Disease Type 3, also identified as Type 3 diabetes or brain insulin resistance. We’ll dissect the triggers, the associated risks, the revealing symptoms, the steps towards a proper diagnosis, the treatment choices available, changes in lifestyle, effective…

[pwrn51]

Type 3 Diabetes and what does that mean

  Have you ever heard the term ‘Type 3 Diabetes’ in reference to Alzheimer’s disease? Have you wondered what that even means? In today’s episode of The Truth, Lies, & Alzheimer’s Show, Lisa shares why some researchers are calling Alzheimer’s disease a ‘Type 3 Diabetes’ and explains why insulin resistance is linked to neurodegenerative disease (Alzheimer’s), and how it affects the body and…

[laureala]

AMELIA SHEPHERD

— in Grey's Anatomy 20.01 - We've Only Just Begun

You told me to say whatever's in my- I'm sorry! It's making me think that maybe Meredith isn't insane.

[mindblowingscience]

A spectrum of neurodegenerative diseases, including frontotemporal dementia (FTD), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) are due to the accumulation of abnormal, misfolded tau proteins in the brain. A team of researchers has found potential ways to interrupt this process by targeting “sticky” sites along the long form of mutated tau, preventing the misfolding and spreading of the neurofibrillary tangles.

Continue Reading.

[ohno-the-sun]

Woot woot more mad scientist au doodles! 

Credit to @oobbbear​ 

Another doodle under the cut (its my favorite but its gory so be warned)

[swinging-stars-from-satellites]

having a hypochondriac moment pray for me babes

[stuckinapril]

My forever struggle is that I’m in love with both neuroscience and medicinal/organic chemistry and I’m just insane enough to be double dipping in both constantly

[evolve-rat]

We’ve moved past people misusing the word twink and people are now calling old Daniel Malloy a bear. Day ruined

[floofyfluff]

we're in this phase III trial of this thing that is soooooooo cool and i want to talk about it sooooo bad but 1. no. 2. no one will understand me if i do. 3. no.

but its so wild to watch disease processes go from totally untreatable to like. one time novel solution. in half of a lifetime. like from "not only do we not know why this is happening or how to stop it but i can tell you that you're just going to go blind," to "well if you come in and get this done every x weeks actually you will preserve most of your vision" to "actually maybe we can just do this one procedure and the thing that robbed 25% of your family of the ability to read by age 75 will simply not be a problem for you"